Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 17, 2013BJU International

Hereditary‐like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin‐based chemotherapy after radical nephroureterectomy than do sporadic tumours

View Full Paper
Ask AI
Bookmark
Share

Authors

CHClémence HollandeInsermPCPierre ColinCentre Hospitalier Universitaire de TivoliTRThibault De La Motte RougeCentre Eugène Marquis

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hollande et al. (2013) studied this question.

synapsesocial.com/papers/6a9fc42740bc1a697f1de412https://doi.org/10.1111/bju.12308
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors2002 · 567 citations
  2. 2Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration2009 · 215 citations
  3. 3Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors2002 · 735 citations
  4. 4Upper Urinary Tract Carcinoma in Lynch Syndrome Cases2011 · 94 citations
  5. 5Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer2003 · 2,179 citations